Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials.
about
Associations between Carotid Artery Plaque Score, Carotid Hemodynamics and Coronary Heart Disease.Carotid ultrasonography: A potent tool for better clinical practice in diagnosis of atherosclerosis in diabetic patients.Common carotid intima media thickness and ankle-brachial pressure index correlate with local but not global atheroma burden: a cross sectional study using whole body magnetic resonance angiographyPrimary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Intima media thickness, pulse wave velocity, and flow mediated dilation.Prolonged combination lipid therapy is associated with reduced carotid intima-media thickness: a case-control study of the 20-year Familial Atherosclerosis Treatment - Observational Study (FATS-OS).Cardiovascular Risk Factors and Nutritional Intake are not Associated with Ultrasound-defined Increased Carotid Intima Media Thickness in Individuals Without a History of Cardiovascular Events.Carotid artery intima-media thickness in college students: race/ethnicity mattersEffects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects.Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and womenThe Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial.Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaborationGender difference in carotid intima-media thickness in type 2 diabetic patients: a 4-year follow-up study.Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.Effect of ezetimibe on major atherosclerotic disease events and all-cause mortality.Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled TrialsPhysical activity ameliorates cardiovascular health in elderly subjects: the functional role of the β adrenergic system.Low-glycaemic index diet to improve glycaemic control and cardiovascular disease in type 2 diabetes: design and methods for a randomised, controlled, clinical trial.Carotid intima-media thickness in patients with mild or moderate psoriasis.Carotid atherosclerosis as a surrogate maker of cardiovascular disease in diabetic patients.Does Carotid Intima-media Thickness have Relationship with Polycystic Ovary Syndrome?Individualization of antihypertensive drug treatment.The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.Coronary Artery Calcium and Carotid Artery Intima Media Thickness and Plaque: Clinical Use in Need of Clarification.Emerging options in the treatment of dyslipidemias: a bright future?The ezetimibe controversy: implications for clinical practice.Attenuation of rate of change in carotid intima-media thickness by lipid-modifying drugs: impact on clinical outcomes.The facts behind niacin.Advances in noninvasive imaging for evaluating clinical risk and guiding therapy in carotid atherosclerosis.Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques.The role of intravascular ultrasound in the determination of progression and regression of coronary artery disease.Lipid-lowering therapy in chronic kidney disease: is there a role for ezetimibe?Assessment of subclinical atherosclerosis by carotid intima media thickness: technical issues.Between risk charts and imaging: how should we stratify cardiovascular risk in clinical practice?Medical management of stable coronary atherosclerosis.Carotid intima-media thickness testing as an asymptomatic cardiovascular disease identifier and method for making therapeutic decisions.Assessment of target organ damage in the evaluation and follow-up of hypertensive patients: where do we stand?Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque RegressionSerial assessment of arterial stiffness by cardio-ankle vascular index for prediction of future cardiovascular events in patients with coronary artery disease.Commentary on R&D Trends Away from General Medicine/Cardiovascular Drugs: Can the FDA Help Reverse the Trend?
P2860
Q30396421-7936F8D5-AA88-4310-AFF7-43179820D772Q33628605-FCF5865B-F19A-441A-B3FE-6CBEB832F0B7Q33763343-0472FE6E-A383-4275-BA05-B36F1721DF8EQ33972551-365FAD39-84EA-4C0E-A806-EEE853A33B65Q34130734-E7F37806-1CF1-4A94-BF14-6387B00BE15DQ34228018-39C1C489-C82D-49FD-AA05-46B5EDF30F29Q34761043-A853EB89-AC09-4CB6-B1B4-E54F1DF50944Q35136765-5F731B5B-A627-433A-972C-ADC9FC15042CQ35560576-3DA4D246-0260-43DC-9F29-BD8DF184FBD2Q35684196-BAE93CBE-4ACD-4A46-8995-601405EE408BQ36063048-E0234316-8CC0-463D-B2DA-BB639C5966FFQ36087284-74757D4C-E03B-4DDC-A1F9-7E7EFA8CEEBEQ36100710-3656EAE7-D1F4-4CEF-A0D0-DA2E98C371B9Q36124203-7C70F19A-4A7B-4F1A-9468-9621A952698EQ36585817-A4F9D53A-2C53-4BA1-9E4D-6BBFF3D0B72EQ36705497-14B63CB3-4949-4DCE-94B6-5B5A8B2DBAB6Q37086960-620788FE-C115-44DF-A798-EDB0C3725563Q37100950-23A83E1F-9812-4A70-A822-B0B752CD4CD3Q37215912-D6B4DFE4-B871-4ED7-A167-820D31EB813EQ37351443-4FA575F7-CD37-42EC-A776-A7251584EB8FQ37443360-7F4D3DD5-0558-49C1-B899-9738CE489E2BQ37577140-16FB64C3-54D8-4A14-A2DA-8E7AB1C9E7CFQ37607759-FB4137F6-EDF7-43F5-8C17-CBAC7F4B5523Q37740344-79CCBF74-D373-4E04-B837-E33AE3E8326DQ37842462-6DBFB34C-5BC0-418C-B984-82D4383C7431Q37884287-5191E08F-B3C6-4122-BA60-9406E519CDC6Q37886975-DFE04151-DCA1-434F-B7E1-BD899C2F6380Q37926768-E1A3FE48-44ED-4633-9FA4-70F01B2BBDDFQ37965656-1A365589-7D6F-449A-BF2B-2430751D94D7Q37973386-A9B9902A-E53C-4FD9-B785-8655E0787210Q37982642-0E17929D-6EC7-491A-93F8-F8E3651ACC67Q38011919-F6B54FF4-8732-4987-A237-D1D4921D382AQ38026700-09C8DA0A-3B8A-4F62-98AB-8F9EA5EF507BQ38072595-23A9C82F-8AED-4B16-BE4B-16A45115A25AQ38083007-39CDBC94-AADA-4F19-9B57-13EAAAF9ED80Q38118481-22423489-1DA8-4A8D-A64E-914E68481213Q38148620-9F7F8EA8-DFDC-49B1-8C0F-8ABDB512D2EBQ38504468-806506C4-7A81-402B-915D-74DE26FD47FBQ39162376-E9680BBC-B3A9-4894-B0D5-C125ED8A50ECQ39388070-905F015C-7004-401E-A07E-C27FCD2A91E4
P2860
Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Does carotid intima-media thic ...... lysis of 41 randomized trials.
@ast
Does carotid intima-media thic ...... lysis of 41 randomized trials.
@en
Does carotid intima-media thic ...... lysis of 41 randomized trials.
@nl
type
label
Does carotid intima-media thic ...... lysis of 41 randomized trials.
@ast
Does carotid intima-media thic ...... lysis of 41 randomized trials.
@en
Does carotid intima-media thic ...... lysis of 41 randomized trials.
@nl
prefLabel
Does carotid intima-media thic ...... lysis of 41 randomized trials.
@ast
Does carotid intima-media thic ...... lysis of 41 randomized trials.
@en
Does carotid intima-media thic ...... lysis of 41 randomized trials.
@nl
P2093
P1476
Does carotid intima-media thic ...... lysis of 41 randomized trials.
@en
P2093
Enrico Vassallo
Gregorio Brevetti
Massimo Chiariello
Paolo Cesarano
Pasquale Perrone-Filardi
Pierluigi Costanzo
Stefania Paolillo
P304
P356
10.1016/J.JACC.2010.05.059
P407
P577
2010-12-01T00:00:00Z